Owens & Minor Stock - Sunday background on the medical supplies specialist
21.06.2026 - 22:02:53 | ad-hoc-news.de
Edited by ad hoc news Background & Management Desk. Verified prior to publication on 06/21/2026, 19:45 UTC. Details in the imprint.
Owens & Minor (US6907321029) is a long-standing US medical products distributor and manufacturer serving hospitals, health systems, and home care providers. With no new investor-relations releases or major wire reports over the past day, today’s focus is a Sunday background on the group’s business, management, and recent positioning.
Background and key data on Owens & Minor stock
Further corporate information, filings and historical news on Owens & Minor are available via the ad hoc news topic page and the company’s investor-relations site.
How the business is positioned
Owens & Minor traces its roots back to 1882 and today focuses on distributing medical and surgical supplies as well as producing private-label and branded products such as surgical drapes, gowns, and exam gloves. The company operates through two main segments, Patient Direct and Products & Healthcare Services, after a strategic reorganization in recent years.
The Patient Direct segment centers on home healthcare and distributes medical supplies directly to patients in categories like diabetes, ostomy, incontinence, and respiratory care. The Products & Healthcare Services segment supplies hospitals, group purchasing organizations, and other care providers with a broad assortment of medical-surgical products, including both third-party brands and Owens & Minor’s own offerings.
Recent financial trajectory and management priorities
In its most recently reported quarter, Owens & Minor generated quarterly revenue in the neighborhood of $2.6 billion, reflecting its scale as a major medical supply player in North America. Management has emphasized improving margins and reducing leverage after a period of acquisition-driven expansion and pandemic-related volatility in demand.
The company’s investor presentations highlight priorities such as optimizing its distribution network, enhancing its product mix, and deepening higher-margin Patient Direct relationships with chronic-care patients. Leadership has also stressed cost discipline and efficiency initiatives in operations and working-capital management to support more stable cash generation over time.
What analysts and the market say
Analyst sentiment on Owens & Minor stock is mixed, with coverage generally reflecting both the company’s essential role in healthcare supply chains and the execution risk around margin improvement and debt reduction. Consensus estimates point to modest revenue growth and a focus on earnings normalization after the pandemic period, alongside efforts to strengthen free cash flow.
On the market side, Owens & Minor shares have historically shown sensitivity to shifts in hospital utilization, procedure volumes, and reimbursement dynamics. Investors also watch developments in group purchasing contracts and competitive pressures from larger distributors when assessing the risk-reward profile.
The background on leadership and governance
Owens & Minor’s board and executive team combine healthcare distribution experience with broader industrial and financial backgrounds, reflecting the company’s dual focus on operational execution and balance-sheet repair. Governance materials show an emphasis on aligning management incentives with long-term shareholder value through performance-based compensation metrics.
In recent years, the group has refreshed parts of its leadership bench and board to support the strategic pivot toward higher-margin areas such as Patient Direct, while maintaining its core hospital supply relationships. This governance evolution is presented as part of a broader transformation narrative that aims to reposition the company for more durable growth and profitability.
The product behind the stock
At the core of Owens & Minor’s offering are medical-surgical supplies such as surgical gowns, drapes, exam gloves, and sterile procedure kits used daily in hospitals and clinics. The company also provides a wide range of home-care products, including ostomy and wound-care items, delivered directly to patients through its Patient Direct channel.
Where the stock trades today
Owens & Minor stock (US6907321029) trades on the New York Stock Exchange under the ticker OMI; the latest available quote shows the shares changing hands in US dollars on that venue.
Key facts on Owens & Minor stock
- Company: Owens & Minor Inc.
- ISIN: US6907321029
- WKN: 861337
- Ticker: OMI
- Venue: New York Stock Exchange (NYSE)
- Price (as of 06/21/2026, 19:45 UTC): latest available quote in USD on NYSE
- Market cap: latest available figure in USD (recent data from NYSE quoting services)
- Sector / Industry: Health Care / Health Care Supplies & Distribution
- Index membership: not a member of major blue-chip indices such as the S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
